FDA approves Olumiant as first systemic therapy for treatment of alopecia areata Dr. Kamal Kant Kohli15 Jun 2022 9:00 AM ISTThe U.S. Food and Drug Administration has approved Olumiant as first systemic therapy for the treatment of alopecia areata.Olumiant...
FIRST: Eli Lilly gets USFDA nod for alopecia areata pill Olumiant Ruchika Sharma14 Jun 2022 1:00 PM ISTOLUMIANT is a once-daily, oral JAK inhibitor discovered by Incyte and licensed to Lilly and is available through specialty pharmacies nationwide.
USFDA nod to Eli Lilly Olumiant for certain hospitalized Covid patients Ruchika Sharma13 May 2022 1:02 PM ISTOLUMIANT is a once-daily, oral JAK inhibitor discovered by Incyte and licensed to Lilly.
WHO panel recommends Eli Lilly Baricitinib, GSK-Vir Biotechnology drug for COVID treatment Ruchika Sharma14 Jan 2022 3:59 PM ISTNew Delhi: The World Health Organization on Friday gave a nod to two new drugs for the treatment of COVID-19 patients with severe and non-severe...
Bajaj Healthcare moves patent office after Eli Lilly refuses to ink Baricitinib agreement Medical Dialogues Team28 Jun 2021 5:45 PM ISTNew Delhi: With Eli Lilly denying to ink voluntary licensing agreement for Baricitinib, Bajaj Healthcare Ltd (BHL) has approached the Indian patent...
Natco Pharma launches Baricitinib in India without patent waiver approval Medical Dialogues Team7 May 2021 3:26 PM ISTNew Delhi: Casting caution to the wind, Natco Pharma has already started distributing its generic version of the rheumatoid arthritis drug Baricitinib...
Eli Lilly arthritis drug baricitinib in combination with remdesivir gets USFDA okay to treat Covid Ruchika Sharma22 Nov 2020 11:00 AM ISTNew Delhi: The U.S. Food and Drug Administration on Thursday approved the emergency use of Eli Lilly and Co's arthritis drug, baricitinib, in...
